REGN1193

DRUG2 trials

Sponsors

Regeneron Pharmaceuticals

Conditions

Diabetes Mellitus, Type 2Healthy Volunteers

Phase 1

An Ascending Single-Dose Study of the Safety, Tolerability and Bioeffect of REGN1193

CompletedNCT01933763

Regeneron PharmaceuticalsHealthy Volunteers

Start: 2013-08-31End: 2015-01-31Updated: 2015-03-13

Study of REGN1193 in Patients With Type 2 Diabetes Mellitus

TerminatedNCT02284425

Regeneron PharmaceuticalsDiabetes Mellitus, Type 2

Start: 2014-10-31End: 2015-12-31Updated: 2016-05-12